ARCHIVES

FDA News: FDA Taking Comments on “First Generic” ANDA Process

This article is from The Cancer Letter archive.

Vol. 40 No. 44 | November 21, 2014

Download PDF Visit The Full Archive

Related Articles

The March: Research Task Force Calls For $10 Billion For NCI In 5 Years

October 23, 1998

The Philadelphia Story: How Surprise Filing by Abramson Spurred Penn to Follow Suit

March 16, 2012

IOM Committee Focuses on Studies Needed To Protect Patients On Omics-Based Trials

November 4, 2011

ACS Board Approves Special Donors Concept, Oks New Program or Cause And Prevention Research

February 23, 1979

Abstracts Of Papers From Gynecologic Oncology Conference

October 17, 1975

NCI Should Toughen Deadlines, Quality, in RAID program, Advisory Committee Says.

October 6, 2006